Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells.

Autor: Kläsener, Kathrin1,2 (AUTHOR), Herrmann, Nadja1,3 (AUTHOR), Håversen, Liliana4 (AUTHOR), Sundell, Timothy3 (AUTHOR), Sundqvist, Martina3 (AUTHOR), Lundqvist, Christina3 (AUTHOR), Manna, Paul T5 (AUTHOR), Jonsson, Charlotte A3 (AUTHOR), Visentini, Marcella6 (AUTHOR), Ljung Sass, Diana7 (AUTHOR), McGrath, Sarah3 (AUTHOR), Grimstad, Kristoffer3,8 (AUTHOR), Aranburu, Alaitz3 (AUTHOR), Mellgren, Karin7 (AUTHOR), Fogelstrand, Linda9,10 (AUTHOR), Forsman, Huamei3 (AUTHOR), Ekwall, Olov3,11 (AUTHOR), Borén, Jan4 (AUTHOR), Gjertsson, Inger3,12 (AUTHOR), Reth, Michael1,2 (AUTHOR)
Zdroj: Clinical & Translational Immunology. 2024, Vol. 13 Issue 10, p1-17. 17p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje